Futura Medical plc (FRA:GYX)

Futura Medical Income Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	7.93	13.93	3.1	-	-	-
Revenue Growth (YoY)	-5.62%	349.09%	-	-	-	-
Cost of Revenue	2.81	4.24	1.33	-	-	-
Gross Profit	5.11	9.69	1.77	-	-	-
Selling, General & Admin	9.64	6.83	6.69	2.74	2.09	1
Research & Development	1.89	1.74	2.05	4.13	3.77	1.93
Other Operating Expenses	-0.13	-0.13	-	-	-	-
Operating Expenses	11.41	8.45	8.74	6.87	5.87	2.93
Operating Income	-6.3	1.24	-6.96	-6.87	-5.87	-2.93
Interest & Investment Income	0.04	0.05	0.07	-	-	0
Pretax Income	-6.26	1.29	-6.89	-6.87	-5.87	-2.93
Income Tax Expense	0.03	-0	-0.38	-1.02	-0.91	-0.52
Net Income	-6.29	1.29	-6.51	-5.85	-4.96	-2.41
Preferred Dividends & Other Adjustments	-	-	-	-	-	-0
Net Income to Common	-6.29	1.29	-6.51	-5.85	-4.96	-2.41
Shares Outstanding (Basic)	303	302	295	287	271	244
Shares Outstanding (Diluted)	303	311	295	287	271	244
Shares Change (YoY)	0.70%	5.38%	2.59%	6.06%	11.21%	19.09%
EPS (Basic)	-0.02	0.00	-0.02	-0.02	-0.02	-0.01
EPS (Diluted)	-0.02	0.00	-0.02	-0.02	-0.02	-0.01
Free Cash Flow	-0.44	-1.34	-0.94	-6.52	-4.29	-4.55
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.02	-0.02	-0.02
Gross Margin	64.49%	69.58%	57.22%	-	-	-
Operating Margin	-79.48%	8.93%	-224.57%	-	-	-
Profit Margin	-79.41%	9.29%	-210.03%	-	-	-
Free Cash Flow Margin	-5.56%	-9.59%	-30.17%	-	-	-
EBITDA	-6.18	1.37	-6.83	-6.85	-5.85	-2.9
EBITDA Margin	-77.91%	9.81%	-220.37%	-	-	-
D&A For EBITDA	0.12	0.12	0.13	0.02	0.02	0.03
EBIT	-6.3	1.24	-6.96	-6.87	-5.87	-2.93
EBIT Margin	-79.48%	8.93%	-224.57%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.